What Is Open Claims Data?
Open claims data is a large-scale collection of healthcare claims information gathered from clearinghouses, pharmacies, providers, and other healthcare transaction sources before those claims are fully adjudicated by health plans. Unlike closed claims data, which comes directly from insurers and reflects finalized reimbursement decisions, open claims data provides a near real-time view of patient diagnoses, treatments, prescriptions, procedures, and provider activity.
What Are the Main Differences Between Open and Closed Claims?
While both data sources offer valuable healthcare insights, they serve different purposes. Many life sciences organizations use both datasets together. Open claims data provides early indicators of market activity, while closed claims data validates trends and supports more comprehensive analyses.
| Open Claims Data | Closed Claims Data |
| Near real-time visibility | Historical, adjudicated view |
| Captured before claim adjudication | Captured after payer processing |
| Broader patient and provider coverage | More complete reimbursement information |
| Faster access to market signals | Higher accuracy and completeness |
| Useful for trend identification | Useful for longitudinal analysis |
Why Is Open Claims Data Important to Pharma Companies?
For pharmaceutical manufacturers, open claims data has become an increasingly important source of commercial intelligence. It offers faster visibility into prescribing trends, patient journeys, treatment adoption, and market dynamics—often weeks or months before similar insights are available through traditional closed claims datasets.
As the life sciences industry seeks to make faster and more informed decisions across commercialization, market access, and patient engagement, open claims data helps fill critical information gaps by providing timely signals about how patients move through the healthcare system.
What Are Some of the Ways that Pharma Companies Use Open Claims Data?
Pharma companies use open claims data in a variety of ways.
- Monitor Product Uptake: Manufacturers can track how quickly newly launched therapies are being prescribed and identify geographic or provider-level adoption trends.
- Identify Treatment Patterns: Open claims data provides insight into patient treatment journeys, including therapy initiation, switching behavior, and discontinuation patterns.
- Improve HCP Targeting: Commercial teams can identify providers treating relevant patient populations and prioritize outreach efforts based on recent treatment activity.
- Support Market Access Strategies: Manufacturers can detect emerging access challenges, understand prescribing behavior across payer segments, and evaluate the impact of formulary changes.
- Enhance Patient Support Programs: Timely claims insights can help manufacturers identify points where patients are facing barriers to treatment initiation or adherence.
What Are Some of the Limitations of Open Claims Data?
Despite its value, open claims data is not a complete picture of healthcare activity. Because claims have not yet been fully adjudicated, some records may have missing information or may never be finalized. In addition, data from multiple sources can sometimes create duplicate records that require cleansing and normalization.
Open claims datasets may not always include complete payer enrollment or reimbursement details, and patient tracking over extended periods can be more challenging than with closed claims datasets. For this reason, many organizations combine open claims data with closed claims data, formulary intelligence, provider data, and other healthcare datasets to create a more comprehensive market view.
